Complexes of GPCR142 and relaxin3 or INSL5, and their production and use

Details for Australian Patent Application No. 2004263512 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Kuei, Chester; Lovenberg, Timothy W.; Chen, Jingcai; Sutton, Steven W.; Liu, Changlu

Agent Shelston IP

Pub. Number AU-A-2004263512

PCT Pub. Number WO2005/014616

Priority 60/493,941 07.08.03 US; 60/580,083 16.06.04 US

Filing date 6 August 2004

Wipo publication date 17 February 2005

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014616 Priority application(s): WO2005/014616

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263514-A variant cell surface molecule associated with cancer

2004263509-Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity